Adjusted daily closes · 252 observations · as of Nov 6, 2026
Historical data, not a forecast
1 month
+6.3%
3 months
-3.0%
6 months
+5.0%
1 year
+25.8%
Year to date
+21.7%
52-week range
$256.02 – $433.73
Fundamental snapshot
Latest reported period: Sep 30, 2026
Sharadar reported data
Market cap
$353.17B
P/E
22.2
P/B
3.6
P/S
0.8
Revenue
$449.66B
Net income
$15.88B
Diluted EPS
17.52
Gross margin
19.80%
Net margin
3.50%
Return on equity
16.40%
Total debt
$74.33B
Cash
$25.85B
Free cash flow
$22.83B
Latest eight reported quarters
Reported quarterly values, newest first
Period
Revenue
Net income
Gross margin
Net margin
Free cash flow
Sep 30, 2026
$112.69B
$4.11B
19.50%
3.60%
$4.26B
Jun 30, 2026
$112.03B
$5.48B
20.80%
4.90%
$10.25B
Mar 31, 2026
$111.72B
$6.28B
22.70%
5.60%
$8.15B
Dec 31, 2025
$113.22B
$10M
16.30%
0.00%
$160M
Sep 30, 2025
$113.16B
$2.35B
18.20%
2.10%
$5.06B
Jun 30, 2025
$111.62B
$3.41B
17.90%
3.10%
$6.3B
Mar 31, 2025
$109.58B
$6.29B
21.70%
5.70%
$4.56B
Dec 31, 2024
$100.81B
$5.54B
21.10%
5.50%
$1.46B
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Bank Julius Baer & Co. Ltd Zurich has acquired a new stake in Humana Inc. (NYSE:HUM) during the third quarter, purchasing 3,065 shares valued at approximately $1,186,000. Several other institutional investors also modified their holdings, with analysts issuing new price targets and maintaining a "Moderate Buy" consensus rating for the insurance provider. Humana recently announced a quarterly dividend of $0.8850, payable on January 29th, 2027.
A federal judge has certified four classes of Facebook users in a class action lawsuit against Meta Platforms Inc., alleging that Meta's Pixel tracking code illegally collected patients' private health information from hospital and doctor websites without consent. The lawsuit covers Facebook users from June 17, 2018, to the present, claiming that Meta matched the collected data to Facebook users for system improvement and advertising. The certified classes are bringing claims rooted in privacy and contract law, including breach of contract and intrusion upon seclusion, seeking damages and a court order to prevent further data collection.
CVS Health is suing the federal government to challenge its 2027 Medicare Advantage star ratings, aiming to avert a potential revenue loss exceeding $2 billion due to declining quality scores. The lawsuit argues that the CMS used illegal methodology and improperly adopted measures to calculate the ratings. CVS joins at least four other insurers in similar lawsuits, all citing a previous ruling that found CMS measures for 2026 scores to be illegal.